Shop Apotheke Europe (ETR:SAE) Given Consensus Rating of “Hold” by Analysts

Shares of Shop Apotheke Europe (ETR:SAE – Get Rating) have been assigned a consensus rating of “N/A” from the ten research firms that are currently covering the stock, Marketbeat reports. The average 1-year target price among analysts that have covered the stock in the last year is €151.40 ($162.80).

SAE has been the topic of several research reports. Credit Suisse Group set a €147.00 ($158.06) price target on shares of Shop Apotheke Europe in a research report on Tuesday, March 8th. Kepler Capital Markets set a €70.00 ($75.27) price target on Shop Apotheke Europe in a report on Tuesday, January 11th. Hauck and Aufhaeuser set a €80.00 ($86.02) price objective on Shop Apotheke Europe in a research report on Thursday, March 3rd. Warburg Research set a €161.00 ($173.12) price target on shares of Shop Apotheke Europe in a research note on Tuesday, April 19th. Finally, Baader Bank set a €125.00 ($134.41) price objective on shares of Shop Apotheke Europe in a research note on Tuesday, April 5th.

Shop Apotheke Europe stock opened at €72.14 ($77.57) on Thursday. Shop Apotheke Europe has a 52 week low of €65.40 ($70.32) and a 52 week high of €189.00 ($203.23). The stock has a market cap of $1.31 billion and a price-to-earnings ratio of -17.39. The company’s 50-day moving average price is €80.60 and its two-hundred day moving average price is €110.92. The company has a current ratio of 3.49, a quick ratio of 2.58 and a debt-to-equity ratio of 54.85.

About Shop Apotheke Europe (Get Rating)

Shop Apotheke Europe N.V. owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was founded in 2001 and is headquartered in Sevenum, the Netherlands.

Read More